Aarkstore - Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Aarkstore - Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Description:

Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic Ovarian Cancer. Browse full report @ – PowerPoint PPT presentation

Number of Views:17

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Aarkstore - Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015


1
Aarkstore - Metastatic Ovarian Cancer-Global
API Manufacturers, Marketed and Phase III Drugs
Landscape, 2015
Category Pharmaceuticals and Healthcare
2
Metastatic Ovarian Cancer-Global API
Manufacturers, Marketed and Phase III Drugs
Landscape, 2015, Report provides comprehensive
insights about phase III pipeline drugs and
marketed drugs across the Metastatic Ovarian
Cancer. A key objective of DelveInsights report
is to establish the understanding for API
Manufacturers for marketed and Phase III Pipeline
drugs across the different countries and regions
for the drugs falling under Metastatic Ovarian
Cancer. The Report gives insights into patents
providing the patent protection data and
marketing exclusivity of all the drugs across the
Metastatic Ovarian Cancer. While the leading
brands, companies and chemicals are considered
thoroughly, DelveInsights report also provides
details on the Global API Manufacturers across
the globe covering Drug Master Filings of US,
Europe and API Manufacturers in Asia specifically
China and India. The research analysis also
presents the global sales forecasts data till
2016.
Browse Complete Report http//www.aarkstore.com
/pharmaceuticals-healthcare/98054/metastatic-ovari
an-cancer-global-api-manufacturers-marketed-and-ph
ase-iii-drugs-landscape-2015
3
Data Sources
  • The report is built using data and information
    sourced from proprietary databases, primary and
    secondary research and in-house analysis by
    DelveInsight team of industry experts.
  • Secondary sources information and data has been
    collected from various printable and
    non-printable sources like search engines, News
    websites, Government Websites, Trade Journals,
    White papers, Magazines, Trade associations,
    Books, Industry Portals, Industry Associations
    and access to available databases.
  • Please note This report requires certain
    updates. We have all the information available
    but require 3 business days to complete the
    process and ensure it is as up-to-date as
    possible. Certain sections in the report may be
    removed or altered based on the availability and
    relevance of data for the indicated disease.
  • .

4
Scope
  • A snapshot of the global Market therapeutics
    scenario for Metastatic Ovarian Cancer.
  • A review of the marketed products under
    prescription for Metastatic Ovarian Cancer,
    regulatory information and marketing status.
  • Coverage of global patent coverage and detailed
    commentaries on the US patent challenges.
  • Graphical representation of investigational
    products for patent expiry and market
    exclusivities across the globe.
  • Product profiles for marketed products for
    Metastatic Ovarian Cancer with complete
    description of mechanism of action, therapeutic
    class, target, route(s) of administration and
    chemical details.
  • Coverage of API Manufacturers for Metastatic
    Ovarian Cancer drugs in the United States, Europe
    and Asian Regions with location details.
  • Coverage of Regulatory filings in theUS, Europe,
    and Asia specifically India and China for
    Metastatic Ovarian Cancer drugs.

5
Reasons to buy
  • Evaluate the marketing status and exclusivity
    details of Metastatic Ovarian Cancer key products
    to exploit opportunities for generic drug
    development opportunities.
  • Identify and understand important and diverse
    types of therapeutics under Phase III development
    for Metastatic Ovarian Cancer.
  • Design effective counter-strategies to gain
    competitive advantage by identifying the key
    patent expiry details and exclusivity with
    respect to Metastatic Ovarian Cancer.
  • API intelligence over marketed drugs for
    Metastatic Ovarian Cancer and gaining primary
    intelligence over active ingredients
    manufacturers across the globe.
  • API intelligence over leading Phase III Pipeline
    drugs.
  • Develop and design strategies by identifying the
    API manufacturers for Phase III Pipeline products
    to enhance and expand business potential and
    scope.

6
Table of Content
  • Indication Overview
  • Marketed Drugs
  • Marketed Details of Drugs by Application Type
  • Marketed Details of Drugs (NDA) by Marketing
    Status
  • Marketed Details of Drugs by Patent Expiration
    Timeline
  • Active Pharmaceutical Ingredient (API)
    Manufacturers Assessment
  • API Manufacturers by United States Drug Master
    File (US DMF) Status
  • API Manufacturers by US DMF Status (Drug
    Specific)
  • API Manufacturers in Europe by Country
  • API Manufacturers in India by State
  • API Manufacturers in China by Province
  • Marketed Details of Approved Drugs by Geography
  • Active Pharmaceutical Ingredient (API)
    Manufacturers Assessment for Phase III Pipeline
    Drugs

7
List of Tables
  • Metastatic Ovarian Cancer Therapeutic Market, US,
    Marketed Drugs by Application Type, 2015
  • Metastatic Ovarian Cancer Therapeutic Market, US,
    Marketed Drugs by Marketing Status, 2015
  • Metastatic Ovarian Cancer Therapeutic Market, US,
    (Year), 2015
  • Metastatic Ovarian Cancer Marketed Drugs, API
    Manufacturers by US DMF Status, 2015
  • Metastatic Ovarian Cancer Marketed Drugs, US DMF
    Status Drug Specific (Number), 2015
  • Metastatic Ovarian Cancer Drugs, API
    Manufacturers, Europe by Country, 2015
  • Metastatic Ovarian Cancer Drugs, API
    Manufacturers, India by State, 2015
  • Metastatic Ovarian Cancer Drugs, API
    Manufacturers, China by Province, 2015
  • Metastatic Ovarian Cancer Drugs, API
    Manufacturers by Geography 2015
  • Metastatic Ovarian Cancer Phase III Pipeline
    Drugs, US DMF Status Drug Specific (Number), 2015
  •  
  •  

8
List of Figures
  • Metastatic Ovarian Cancer Therapeutic Market, US,
    Marketed Drugs by Application Type (), 2015
  • Metastatic Ovarian Cancer Therapeutic Market, US,
    Marketed Drugs by Marketing Status (), 2015
  • Metastatic Ovarian Cancer Therapeutic Market, US,
    (Year), 2015
  • Metastatic Ovarian Cancer Marketed Drugs, API
    Manufacturers by US DMF Status (), 2015
  • Metastatic Ovarian Cancer Marketed Drugs, US DMF
    Status Drug Specific (Number), 2015
  • Metastatic Ovarian Cancer Drugs, API
    Manufacturers, Europe by Country, 2015
  • Metastatic Ovarian Cancer Drugs, API
    Manufacturers, India by State, 2015
  • Metastatic Ovarian Cancer Drugs, API
    Manufacturers, China by Province, 2015

9
Related reports
  •  
  • Global Crohns Disease (CD) Market 2015-2019
  • Global Chronic Kidney Disease (CKD) Drugs Market
    2015-2019
  • Global Acquired Orphan Blood Diseases
    Therapeutics Market 2015-2019
  • Womens Health - Assessing the Need for a
    Targeted and Specialized Approach
  • Global Travel Vaccines Market 2015-2019
  • Global Acquired Orphan Blood Diseases
    Therapeutics Market 2015-2019
  • Patient Monitoring and Diagnostic Systems Markets
    in China
  • Hearing Aids Markets in China
  • Medical Imaging System and Equipment Markets in
    China
  • Medical Devices Markets in China

10
  • Metastatic Ovarian Cancer-Global API
    Manufacturers, Marketed and Phase III Drugs
    Landscape, 2015
  • Published Feb 2015 100 Pages
  • The Report gives insights into patents providing
    the patent protection data and marketing
    exclusivity of all the drugs across the
    Metastatic Ovarian Cancer
  • Price

Format Price
PDF 2000
Site License 4000
Enterprise Wide License 6000
11
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953
  • You Can Visit http//www.aarkstore.com
  • OR Mail us at contact_at_aarkstore.com
  • Blog
  • http//www.aarkstore.com/blog/
  • Conference
  • http//conference.aarkstore.com/
  • News
  • http//www.aarkstore.com/news
About PowerShow.com